Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?

INTRODUCTION: Cerebrospinal fluid (CSF) neurodegenerative markers are measured clinically to support a diagnosis of Alzheimer's disease. Several preanalytical factors may alter the CSF concentrations of amyloid β 1–42 (Aβ1–42) in particular with the potential to influence diagnosis. We aimed to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement (Amst)
Main Authors: Paterson, Ross W., Toombs, Jamie, Chapman, Miles D., Nicholas, Jennifer M., Heslegrave, Amanda J., Slattery, Catherine F., Foulkes, Alexander J.M., Clark, Camilla N., Lane, Christopher A.S., Weston, Philip S.J., Lunn, Michael P., Fox, Nick C., Zetterberg, Henrik, Schott, Jonathan M.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2015
Assuntos:
CSF Biomarkers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4877931/
https://ncbi.nlm.nih.gov/pubmed/27239518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2015.06.003
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados